Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Resources

Senate GOP Leaders Urge CMS to Preserve Six Protected Classes Policy

3/7/2014

 
Picture
In a letter to the Department of Health and Human Services (HHS), key Republican leaders urged HHS to rescind a proposed rule that could threaten access to prescription drugs for seniors and people with disabilities. In the letter—spearheaded by Sen. Marco Rubio (R-FL) and signed by 15 Senate Republicans—the Senators urge CMS to retract the ruling immediately, indicating that “the most important pillars of the Part D program have been its robust competition among plans, protection from government interference in contract negotiations, and protection of access to life-saving drugs.” The Senators warn that the proposed rule could “undermine each of these pillars,” resulting in as many as 14 million seniors losing their current drug coverage. Click the document below to view the letter.

Rubio Senate R Part D Rule Letter to Sebelius 03-07-14
File Size: 380 kb
File Type: pdf
Download File


Comments are closed.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    March 2021
    February 2021
    November 2020
    January 2020
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    July 2018
    June 2018
    March 2018
    January 2018
    September 2017
    August 2016
    June 2016
    March 2016
    September 2014
    March 2014
    February 2014
    January 2014
    July 2011
    September 2010
    March 2010
    July 2008
    January 2008
    December 2003

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.